Decoy Therapeutics Inc. (NasdaqCM: DCOY)
Health Care · Biotechnology · US
$1.17
-20.41% today · -97.6% 1Y
Decoy Therapeutics Inc. (NasdaqCM: DCOY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $766.57K and employs 11 people.
Over the last twelve months the share price has lost 97.6%, trading between 1.15 and 51.13.
Tweenvest scores Decoy Therapeutics Inc. across four factors: quality 35/100, value 33/100. Its strongest factor is quality.
DCOY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $766.57K
- Revenue (TTM)
- $227.63K
- P/E
- —
- EPS
- -40.40
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- $51.13
- 52-week low
- $1.15
- Avg volume (3M)
- —
- Shares outstanding
- 655.18K
- Employees
- 11
- Next earnings
- —
About Decoy Therapeutics Inc.
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
- ISIN
- US79400X6022
- Listed since
- Jan 29, 2015
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Silexion Therapeutics CorpNasdaqCM: SLXN | $850.72K | $0.15 | -28.70% |
| Alligator Bioscience AB (publ)OM: ATORX | $837.19K | Skr0.01 | -13.73% |
| Agentix Corp.OTCPK: AGTX | $801.34K | $0.02 | — |
| Hindustan Bio Sciences LimitedBSE: 532041 | $766.86K | Rs7.10 | -4.70% |
| Helix BioMedix, Inc.OTCPK: HXBM | $739.29K | $— | — |
| Smart Agro - LimitedTASE: SMAG | $731.90K | ₪0.54 | -1.29% |
| Nutra Pharma Corp.OTCPK: NPHC | $715.97K | $0.00 | +9900.00% |
| SQZ Biotechnologies CompanyOTCPK: SQZB | $707.79K | $0.02 | -0.41% |
Figures last refreshed Oct 18, 2026.